Adverse Drug Reactions - Part I
COURSE NUMBER: 536
Kristin A. Williams, DDS, MPH; M. Louay Taifour, BDS, DMD
The objectives of this course are to present the mechanisms of ADRs characterized by (1) “on-target”, (2) “off-target”, and (3) cytotoxic reactions; provide a clinical frame of reference for ADRs; and to raise the level of awareness of oral...
(Use this feature to create assignments for your students and staff.)
The objectives of this course are to present the mechanisms of ADRs characterized by (1) “on-target”, (2) “off-target”, and (3) cytotoxic reactions; provide a clinical frame of reference for ADRs; and to raise the level of awareness of oral healthcare providers of the spectrum of potential ADRs affecting oral tissues and various organ systems.
In addition, this course presents the mechanisms of adverse drug reactions (ADRs), the 30 most common ADRs associated with the top 200 drugs dispensed by U.S. community pharmacies, and less common ADRs that relate to dental therapeutics and/or manifest in the head and neck area. Emphasis is on those ADRs that have a pharmacokinetic or a pharmacodynamic basis and, with the exception of overdose, are the result of drug-drug, drug-food, drug-herbal, and drug-disease interactions with therapeutic doses of drugs.
Dentists, Dental Hygienists, Dental Assistants, Dental Students, Dental Hygiene Students, Dental Assisting Students
Date Course Online:
Jul 1, 2017
Last Revision Date:
Jul 1, 2019
Course Expiration Date:
Dec 30, 2022
AGD Subject Code(s):
Upon completion of this course, the dental professional should be able to:
- Discuss in general terms the approval process of new drugs and its limitations as they relate to ADRs.
- Discuss “on-target,” “off-target,” and cytotoxic mechanisms of ADRs.
- Develop a clinical frame of reference related to ADRs.
- Discuss the spectrum of potential ADRs affecting the head and neck area and various organ systems associated with dental therapeutics and the top 200 drugs dispensed by U.S. community pharmacies.
P&G is providing these resource materials to dental professionals. We do not own this content nor are we responsible for any material herein.
Participants must always be aware of the hazards of using limited knowledge in integrating new techniques or procedures into their practice. Only sound evidence-based dentistry should be used in patient therapy.
__Note: __ Registration is required to take test.
Academy of General Dentistry (AGD) Submission For credit transfers to appear in your AGD account in real time, make sure to add your AGD membership number in the field provided on the “Share Your Test Score” page.
CE Broker For all states that use CE Broker for licensure, “proof of completions” are electronically reported the first of every month. If a course was taken in November, the “proof of completion” will be submitted the beginning of December.
ADA CERP Recognized Provider
The Procter & Gamble Company is an ADA CERP Recognized Provider.
ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry.
Concerns or complaints about a dental CE provider may be directed to the provider or to ADA CERP at CCEPR.ADA.org.
Approved PACE Program Provider
THE PROCTER & GAMBLE COMPANY
Nationally Approved PACE Program Provider for FAGD/MAGD credit.
Approval does not imply acceptance by any regulatory authority or AGD endorsement.
8/1/2021 to 7/31/2027
Provider ID# 211886
AADH Approved Program Provider
Procter & Gamble is designated as an approved Provider by the American Academy of Dental Hygiene, Inc. #AADHPGC (January 1, 2022-December 31, 2023). Approval does not imply acceptance by a state or provincial Board of Dentistry. Licensee should maintain this document in the event of an audit.